Activity
Activity Description
Using a committee established by the Institute of Medicine (IOM), the IOM provided advice to the Centers for Disease Control and Prevention (CDC) and program managers on selected aspects of pre-event smallpox vaccination program implementation.
PROJECT OBJECTIVES
The Committee reviewed and made recommendations to CDC and the vaccine program managers to improve:
- CDC guidelines and instruments to identify potential vaccine recipients at high risk of vaccine adverse events and complications,
- CDC measures to ensure the early recognition, evaluation, and appropriate treatment of adverse events and complications of smallpox vaccination,
- CDC plans for collecting and analyzing data on vaccine immunogenicity, adverse events, complications, and vaccine coverage,
- the informed consent process for vaccine recipients,
- professional education and training materials,
- communication plans developed by CDC for public health and medical professionals and the public,
- state smallpox vaccination implementation plans, and
- the achievement of overall goals of the smallpox vaccination program (e.g. vaccine coverage rate, equity of access, adverse reaction rates, etc.).
For more information